Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma

This study has been completed.
Sponsor:
Collaborators:
Massachusetts General Hospital
Biogen Idec
Information provided by (Responsible Party):
Jennifer R. Brown, MD, PhD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT00119730
First received: July 7, 2005
Last updated: April 22, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)